Insider · CIK 0001451767

GARCEAU ROGER

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001451767

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31K sh	—	—	31,000
2025-06-12	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2024-06-07	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2024-01-01	ENTXEntera Bio Ltd. · Stock Option (right to buy)A Award	Director	AAward	+108K sh	—	—	108,333
2023-06-07	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2023-01-02	ENTXEntera Bio Ltd. · Stock Option (right to buy)A Award	Director	AAward	+89K sh	—	—	89,041
2022-06-08	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2022-01-01	ENTXEntera Bio Ltd. · Stock Option (right to buy)A Award	Director	AAward	+35.9K sh	—	—	35,852
2022-01-01	ENTXEntera Bio Ltd. · Stock Option (right to buy)A Award	Director	AAward	+108K sh	—	—	107,557
2021-06-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-06-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2020-01-10	TARAProtara Therapeutics, Inc.A Award	Director	AAward	+33K sh	—	—	33,000
2020-01-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,399
2020-01-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,399
2020-01-09	TARAProtara Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,491
2015-02-21	NPS PHARMACEUTICALS INCU Disposition from Tender	SVP & CMO	UDisposition from Tender	−43.3K sh	$46.00	−$1.99M	0
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	SVP & CMO	DDisposition to Issuer	−30.6K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	SVP & CMO	DDisposition to Issuer	−84.9K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	SVP & CMO	DDisposition to Issuer	−9,900 sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	SVP & CMO	DDisposition to Issuer	−25.2K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	SVP & CMO	DDisposition to Issuer	−26K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	SVP & CMO	DDisposition to Issuer	−10.9K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	SVP & CMO	DDisposition to Issuer	−7,665 sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	SVP & CMO	DDisposition to Issuer	−10.5K sh	—	—	0
2015-02-13	NPS PHARMACEUTICALS INCM Exercise/Conversion	SVP & CMO	MExercise/Conversion	+10.5K sh	—	—	48,809
2015-02-13	NPS PHARMACEUTICALS INCF Tax Payment	SVP & CMO	FTax Payment	−5,460 sh	$45.88	−$251K	43,349
2015-02-13	NPS PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP & CMO	MExercise/Conversion	−10.5K sh	—	—	10,531
2015-02-12	NPS PHARMACEUTICALS INCM Exercise/Conversion	SVP & CMO	MExercise/Conversion	+3,832 sh	—	—	39,842
2015-02-12	NPS PHARMACEUTICALS INCF Tax Payment	SVP & CMO	FTax Payment	−1,564 sh	$45.85	−$71.7K	38,278
2015-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP & CMO	MExercise/Conversion	−3,832 sh	—	—	7,665
2015-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP & CMO	AAward	+10.9K sh	—	—	10,905
2015-02-10	NPS PHARMACEUTICALS INCG Gift	SVP & CMO	GGift	−11K sh	—	—	41,448
2015-02-07	NPS PHARMACEUTICALS INCJ Other	SVP & CMO	JOther	+15.2K sh	—	—	41,448
2015-02-07	NPS PHARMACEUTICALS INCF Tax Payment	SVP & CMO	FTax Payment	−5,438 sh	$45.85	−$249K	36,010
2015-02-05	NPS PHARMACEUTICALS INCM Exercise/Conversion	SVP & CMO	MExercise/Conversion	−15.4K sh	$45.88	−$706K	52,448
2014-02-13	NPS PHARMACEUTICALS INCM Exercise/Conversion	SVP & CMO	MExercise/Conversion	+10.5K sh	—	—	71,754
2014-02-13	NPS PHARMACEUTICALS INCF Tax Payment	SVP & CMO	FTax Payment	−3,922 sh	$38.30	−$150K	67,832
2014-02-13	NPS PHARMACEUTICALS INCRestricted Stock UnitsM Exercise/Conversion	SVP & CMO	MExercise/Conversion	−10.5K sh	—	—	21,062
2014-02-12	NPS PHARMACEUTICALS INCEmployee Stock Options (right to buy)A Award	SVP & CMO	AAward	+31.5K sh	—	—	31,474
2014-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP & CMO	AAward	+11.5K sh	—	—	11,497
2014-02-07	NPS PHARMACEUTICALS INCJ Other	SVP & CMO	JOther	+15.2K sh	—	—	66,595
2014-02-07	NPS PHARMACEUTICALS INCF Tax Payment	SVP & CMO	FTax Payment	−5,371 sh	$35.13	−$189K	61,224
2014-01-07	NPS PHARMACEUTICALS INCStock OptionsA Award	SVP & CMO	AAward	+15K sh	—	—	125,758
2013-08-30	NPS PHARMACEUTICALS INCM Exercise/Conversion	SVP & CMO	MExercise/Conversion	+74.2K sh	$3.34	+$248K	138,388
2013-08-30	NPS PHARMACEUTICALS INCM Exercise/Conversion	SVP & CMO	MExercise/Conversion	+9,375 sh	$5.98	+$56.1K	147,763
2013-08-30	NPS PHARMACEUTICALS INCM Exercise/Conversion	SVP & CMO	MExercise/Conversion	+26.4K sh	$8.25	+$218K	174,146
2013-08-30	NPS PHARMACEUTICALS INCS Sale	SVP & CMO	SSale	−110K sh	$25.18	−$2.77M	64,146
2013-08-30	NPS PHARMACEUTICALS INCStock OptionsM Exercise/Conversion	SVP & CMO	MExercise/Conversion	−1,622 sh	—	—	8,378
2013-08-30	NPS PHARMACEUTICALS INCStock OptionsM Exercise/Conversion	SVP & CMO	MExercise/Conversion	−12.6K sh	—	—	27,380
2013-08-30	NPS PHARMACEUTICALS INCStock OptionsM Exercise/Conversion	SVP & CMO	MExercise/Conversion	−60K sh	—	—	20,000

Recent filings

Accepted (ET)
Jun 164
GARCEAU ROGER0001213900-26-069245
SEC(opens sec.gov)
Jun 134
GARCEAU ROGER0001213900-25-054283
SEC(opens sec.gov)
Jun 104
GARCEAU ROGER0001213900-24-051376
SEC(opens sec.gov)
Jan 34
GARCEAU ROGER0001178913-24-000055
SEC(opens sec.gov)
Jun 84
GARCEAU ROGER0001213900-23-047472
SEC(opens sec.gov)
Jan 44
GARCEAU ROGER0001178913-23-000055
SEC(opens sec.gov)
Jun 94
GARCEAU ROGER0001213900-22-031991
SEC(opens sec.gov)
Jan 114
GARCEAU ROGER0001178913-22-000089
SEC(opens sec.gov)
Jun 104
GARCEAU ROGER0001209191-21-039683
SEC(opens sec.gov)
Jun 114/A
GARCEAU ROGER0001209191-20-035847
SEC(opens sec.gov)
Jun 114
GARCEAU ROGER0001209191-20-035848
SEC(opens sec.gov)
Jan 134
GARCEAU ROGER0001209191-20-003239
SEC(opens sec.gov)
Feb 244
NPS PHARMACEUTICALS INC0001104659-15-013592
SEC(opens sec.gov)

Companies

Address

C/O PROTARA THERAPEUTICS, INC. 345 PARK AVENUE SOUTH, 3RD FLOOR

NEW YORK, NY, 10010